Paramedic Papers

Home Paediatrics IM beats intranasal midazolam in paediatric seizures

Paediatrics

IM beats intranasal midazolam in paediatric seizures

Intranasal Versus Intramuscular Midazolam in Pediatric Seizure Control: A Systematic Review and Meta-Analysis
Prehospital Emergency Care · Added 6 May 2026

Meta-analysis testing whether intranasal or intramuscular midazolam works better for paediatric seizures without cannula access — intramuscular midazolam was associated with faster seizure termination and less need for rescue therapy, especially in the prehospital setting.

Study type
Systematic review
Design
Systematic review and meta-analysis (random-effects)
Participants
5 studies, 3,933 paediatric seizure patients (97.9% prehospital)
Main finding
IM midazolam associated with less rescue therapy (RR 1.29; 95% CI 1.15–1.45), shorter time to seizure termination (MD 23.60 s; 95% CI 2.31–44.89), persisting at 0.2 mg/kg dose.
Caveat
Only five studies, observational comparison of routes with possible confounding
Bottom line
Supports current practice

Learning goal

Weigh the benefits and limitations of intranasal midazolam when intramuscular access is unavailable in paediatric seizures.

Open in dashboard Read the paper (DOI) PubMed

More

Related papers on Paediatrics